PDS Biotechnology Corp (PDSB)
3.25
+0.02
(+0.46%)
USD |
NASDAQ |
Nov 05, 16:00
3.25
0.00 (0.00%)
After-Hours: 20:00
PDS Biotechnology Enterprise Value: 85.61M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 85.61M |
| November 01, 2024 | 84.32M |
| October 31, 2024 | 83.95M |
| October 30, 2024 | 84.87M |
| October 29, 2024 | 85.05M |
| October 28, 2024 | 88.00M |
| October 25, 2024 | 81.37M |
| October 24, 2024 | 81.00M |
| October 23, 2024 | 81.19M |
| October 22, 2024 | 86.53M |
| October 21, 2024 | 81.37M |
| October 18, 2024 | 86.16M |
| October 17, 2024 | 80.63M |
| October 16, 2024 | 83.21M |
| October 15, 2024 | 85.42M |
| October 14, 2024 | 87.26M |
| October 11, 2024 | 92.42M |
| October 10, 2024 | 88.37M |
| October 09, 2024 | 91.68M |
| October 08, 2024 | 97.57M |
| October 07, 2024 | 103.83M |
| October 04, 2024 | 103.09M |
| October 03, 2024 | 112.30M |
| October 02, 2024 | 117.82M |
| October 01, 2024 | 100.89M |
| Date | Value |
|---|---|
| September 30, 2024 | 107.14M |
| September 27, 2024 | 90.58M |
| September 26, 2024 | 81.74M |
| September 25, 2024 | 78.06M |
| September 24, 2024 | 81.74M |
| September 23, 2024 | 82.11M |
| September 20, 2024 | 84.32M |
| September 19, 2024 | 84.68M |
| September 18, 2024 | 79.53M |
| September 17, 2024 | 81.37M |
| September 16, 2024 | 79.16M |
| September 13, 2024 | 76.95M |
| September 12, 2024 | 78.79M |
| September 11, 2024 | 80.63M |
| September 10, 2024 | 77.32M |
| September 09, 2024 | 77.32M |
| September 06, 2024 | 74.38M |
| September 05, 2024 | 76.95M |
| September 04, 2024 | 77.32M |
| September 03, 2024 | 77.69M |
| August 30, 2024 | 84.32M |
| August 29, 2024 | 82.48M |
| August 28, 2024 | 80.27M |
| August 27, 2024 | 81.37M |
| August 26, 2024 | 83.58M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-11.07M
Minimum
Apr 02 2020
410.73M
Maximum
Sep 23 2021
107.12M
Average
95.55M
Median
Nov 02 2022
Enterprise Value Benchmarks
| Chimerix Inc | -59.43M |
| Cellectar Biosciences Inc | 64.32M |
| Marinus Pharmaceuticals Inc | 10.41M |
| Jaguar Health Inc | 26.16M |
| Seres Therapeutics Inc | 151.90M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.328M |
| Total Expenses (Quarterly) | 8.684M |
| EPS Diluted (Quarterly) | -0.23 |
| Earnings Yield | -37.85% |